Private Wealth Management Group, LLC Vaxcyte, Inc. Transaction History
Private Wealth Management Group, LLC
- $301 Billion
- Q2 2025
A detailed history of Private Wealth Management Group, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 20 shares of PCVX stock, worth $853. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 36
44.44%
Holding current value
$853
Previous $1.36 Million
52.13%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PCVX
# of Institutions
324Shares Held
139MCall Options Held
229KPut Options Held
160K-
Janus Henderson Group PLC London, X014.7MShares$627 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$512 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA12MShares$510 Million8.5% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$424 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6MShares$256 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.53B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...